Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |